S16C (p.Ser16Cys) variant of CASQ2 (Calsequestrin-2)
S16C (p.Ser16Cys) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
S16C (p.Ser16Cys) variant details
- p.Ser16Cys
- NCI-TCGA Cosmic COSV9979
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available